Register for this webinar to learn about the advanced achievements in preclinical CAR-T cell therapy research for the fight against CANCER!!
[ Ссылка ]
The landscape of CAR T-cell therapy research extends beyond its current applications, encompassing investigations into the utilization of existing FDA-approved products for novel indications and in populations with limited treatment options. Concurrently, efforts are underway to enhance the safety profile of CAR T-cell therapy, thereby mitigating potential adverse events associated with its administration. The ongoing advancements in CAR T-cell therapy research evoke a sense of optimism within the cancer community, fostering anticipation for its future prospects and the transformative impact it holds for individuals affected by cancer.
Based on years of research experience in the field of tumor immunotherapy, Cyagen can provide comprehensive services and support for the research and development of CAR-T and other cell therapies.
Cell & Animal Models for Immune-Oncology and CAR-T Cell Therapy could be found at:
[ Ссылка ]
CRO Services for Immune Cell Therapy could be found at:
[ Ссылка ]
Discover Cyagen’s One-Stop Preclinical Ophthalmology Research Solutions at:
[ Ссылка ]
Neurobehavioral Platform Services for Rat and Mouse Projects could be found at
[ Ссылка ]
iPSC Disease Models Services could be found at:
[ Ссылка ]
You can find all our services on our website: www.cyagen.com/us/en/
Follow us on Social Media: Youtube: [ Ссылка ]
Twitter: [ Ссылка ]
Linkedin: [ Ссылка ]
Facebook: [ Ссылка ]
Email：
animal-service@cyagen.com (Animal Model Services)
animal-bank@cyagen.com (Cyagen Catalog Models)
cell-service@cyagen.com (Cell Products and Services)
